Search details
1.
Loss of ZNF451 mediates fibroblast activation and promotes lung fibrosis.
Respir Res
; 25(1): 160, 2024 Apr 10.
Article
in English
| MEDLINE | ID: mdl-38600524
2.
CC Chemokines in Idiopathic Pulmonary Fibrosis: Pathogenic Role and Therapeutic Potential.
Biomolecules
; 13(2)2023 02 09.
Article
in English
| MEDLINE | ID: mdl-36830702
3.
MiR-297 inhibits tumour progression of liver cancer by targeting PTBP3.
Cell Death Dis
; 14(8): 564, 2023 08 26.
Article
in English
| MEDLINE | ID: mdl-37633911
4.
The chemokine CCL1 facilitates pulmonary fibrosis by promoting macrophage migration and M2 polarization.
Int Immunopharmacol
; 120: 110343, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37220693
5.
CCL17 drives fibroblast activation in the progression of pulmonary fibrosis by enhancing the TGF-ß/Smad signaling.
Biochem Pharmacol
; 210: 115475, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36870575
6.
ZNF451 favors triple-negative breast cancer progression by enhancing SLUG-mediated CCL5 transcriptional expression.
Cell Rep
; 42(6): 112654, 2023 06 27.
Article
in English
| MEDLINE | ID: mdl-37342906
7.
TRAF6 Suppresses the Development of Pulmonary Fibrosis by Attenuating the Activation of Fibroblasts.
Front Pharmacol
; 13: 911945, 2022.
Article
in English
| MEDLINE | ID: mdl-35668944
8.
Phenotype and biological characteristics of endometrial mesenchymal stem/stromal cells: A comparison between intrauterine adhesion patients and healthy women.
Am J Reprod Immunol
; 85(6): e13379, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33206449
9.
TRIB3âGSK-3ß interaction promotes lung fibrosis and serves as a potential therapeutic target.
Acta Pharm Sin B
; 11(10): 3105-3119, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-34729304
Results
1 -
9
de 9
1
Next >
>>